Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Name Common Trade Name(s) Classificationsort icon Date Marketed in Canada (yyyy/mm/dd)
Ondansetron Ondissolve ODF Antiemetic 2013/04
Palonosetron + netupitant Akynzeo Antiemetic 2017/12/04
Rufinamide Banzel Antiepileptic 2011/09
Stiripentol Diacomit Antiepileptic 2014/12/21
Brivaracetam Brivlera Antiepileptic agent 2016/05/10
Bilastine Blexten Antihistamine 2016/12/02
Azelastine + fluticasone Dymista Antihistamine and corticosteroid agent 2015/10/22
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Canagliflozin Invokana antihyperglycemic agent 2014/06/25
Albiglutide Eperzan Antihyperglycemic agent 2016/02/19
Dulaglutide Trulicity Antihyperglycemic agent 2016/01/08
Olmesartan + hydrochlorothiazide Olmetec Plus Antihypertensive agent 2009/02
Olmesartan Olmetec Antihypertensive agent 2009/02
Azilsartan Edarbi Antihypertensive agent 2013/03/27
Azilsartan + chlorthalidone Edarbyclor Antihypertensive agent 2013/03/27
Mefloquine Lariam Antimalarial agent 2012/07/06
Lithium, sustained release Lithmax Antimanic agents
Clindamycin + tretinoin Biacna Antimicrobial + keratolytic 2010/04
Glycopyrrolate Cuvposa Antimuscarinic antispasmodic agent 2018/04/03
Degarelix Firmagon Antineoplastic agent 2009/11
Lapatinib ditosylate Tykerb Antineoplastic agent 2009/05
Azacitidine Vidaza Antineoplastic agent 2009/12/07
Everolimus Afinitor Antineoplastic agent 2010/02/12
Trabectedin Yondelis Antineoplastic agent 2010/08/04
Lenalidomide Revlimid Antineoplastic agent
Pazopanib Votrient Antineoplastic agent 2011/08/25
Ipilimumab Yervoy Antineoplastic agent 2012/03
Cabazitaxel Jevtana Antineoplastic agent 2011/06
Eribulin Halaven Antineoplastic agent 2012/03/10
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Ofatumumab Arzerra Antineoplastic agent 2012/03/09
Vemurafenib Zelboraf Antineoplastic agent 2012/02
Pertuzumab Perjeta Antineoplastic agent 2013/04/23
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Trastuzumab emtansine Kadcyla Antineoplastic agent 2013/09/27
Bendamustine Treanda Antineoplastic agent 2012/09/12
Syndicate content